Multiple Myeloma with a Special Focus on Precision Medicine
Multiple myeloma (MM) is the most common hematological malignancy. Risk stratification was relevantly refined in recent years regarding, among others, the revised international staging system (R-ISS) and expanded knowledge about the influence of cytogenetic abnormalities. The introduction of the &qu...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2020-12-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2020.06.023 |